A recent study in two independent DLBCL cohorts uncovered similar trends in TIM3+LAG3+ TIL abundance in these diseases, and these cells were found to be an independent predictor of poor survival (Autio et al., 2021). Here, LAG3 is linked to diffuse large B-cell lymphoma.